Mark Cuban Cost Plus Drug Company Partners With Drexi To Deliver Better Access To Affordable Medications For Self-Funded Plans

Drexi, a pharmacy benefit manager (PBM), and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), partnered to offer Drexi’s self-funded plan clients with access to medications through Cost Plus Drugs. Drexi is a subsidiary of Advanced Medical Pricing Solutions (AMPS). Through the collaboration with Cost Plus Drugs, Drexi now provides members with an additional channel through which they can more effectively recognize cost savings opportunities and act on them: empowering them to take back control of their healthcare spending.

Cost Plus Drugs aims to change the way the pharmaceutical industry operates. As a public-benefit corporation . . .